We conclude from above data that liver GPS2 expression and function could be causatively correlated with the progression of NAFLD towards NASH via regulating PPARα-coupled liver lipid metabolism (Fig. 6h). The gene discussed is GPS2; the disease is metabolic dysfunction-associated steatotic liver disease.